The destination is to get to a point where we can spend our healthcare resources more wisely so that patients get the care they need and we all get the type of innovation that we really want, said Robert Dubois, MD, PhD, chief science officer and executive vice president, National Pharmaceutical Council.
The destination is to get to a point where we can spend our healthcare resources more wisely so that patients get the care they need and we all get the type of innovation that we really want, said Robert Dubois, MD, PhD, chief science officer and executive vice president, National Pharmaceutical Council.
Trascript (slightly modified)
What do you think are the most important questions that currently need to be addressed in the conversation about healthcare spending?
I think there’s a number of important questions that need to be addressed regarding healthcare spending, and I think there’s tier 1 questions and tier 2 questions. The tier 1 questions are really the high-level ones: How much do we want to spend on healthcare in the United States? And then, how do we allocate those dollars? So those are the high-level questions.
Then underneath it is where it gets to be difficult. It’s what I like to call the third rail questions: should we be spending more in preventive care than actual treatment? Should we be spending different amounts on end-of-life care or on the elderly versus the younger folks? Should we be spending the same amount on cancer care that we do today, or should we allocate those resources differently? That’s the second-tier questions, and those frankly are the really tough ones, but unless we address those, we really won’t come up with any solutions.
What will the consequences be for the US economy if unchecked healthcare spending is not addressed?
Too often we say the problem is drug spending or the problem is hospital consolidation raising the cost of going into the hospital. That’s looking at things individually and finger pointing. What we need to do is not just look at the costs of these services, but also the benefits. So, what’s the cost of hospital care, and what are the benefits? What are the costs of medications or devices or surgery, and what are the benefits?
Only by looking at those side by side can we decide, “You know, I think we’d be better off reallocating some of our resources, which are currently being spent on things that are not high value, and shifting those dollars towards things that in fact are high value.”
We are on a journey, and the journey really is to begin to talk about these kind of things, but the destination isn’t just to talk. The destination is to get to a point where we can spend our healthcare resources more wisely so that patients get the care they need and we all get the type of innovation that we really want.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More